Citations

Clear

336 citation(s) found for "Griffin, S M".

Pulmonary Function Test Order Redesign: A Quality Improvement Initiative
Sujanyal, Saurabh, Omercikoglu, Elcin , Alazab, Heba, Griffin, Angie, Koirala, Tapendra , Burger, Charles, Beagle, Lisa, Atkins, Shannon, Helgeson, Scott A. , Helgeson, Scott A , Alazab, Heba

Mayo Clinic

Journal of Patient Safety | September 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/pts.0000000000001590 | PMID 42748326 Get It

Objectives: Pulmonary function tests (PFTs) are essential for diagnosis, management, and follow-up of a wide range of respiratory conditions as they provide quantitative insights into various aspects of lung function. Precision in ordering and scheduling PFTs, like any test, is crucial as errors can lead to misdiagnoses, delayed treatments, unnecessary retesting, inflated healthcare costs, and potentially compromised patient care. Hence, the aim of this quality improvement initiative was to reduce the PFT ordering error rate to below 5% by redesigning the ordering workflow and implementing a standardized order set tailored to specific clinical scenarios. Methods: The quality improvement initiative was implemented from August 2023 to March 2024. Data was collected from the electronic medical record (EMR) using predefined operational definitions to identify incorrect PFT orders and scheduling errors. A redesigned orderset was created to align with specific clinical presentations, including symptoms, suspected diagnosis, confirmed diagnosis, and presurgical evaluation. Scheduling was also restructured to match the expected testing time for each category. Education sessions were conducted with ordering providers, and ongoing feedback loops were established. Results: Among 575 preintervention PFT orders, 130 (22.6%) contained errors. Following implementation, review of 607 postintervention orders showed a reduction in error rates to 4.1%, representing an ∼80% improvement ( P <0.01). There was no increase in unnecessary testing, supporting the effectiveness of the intervention without unintended negative consequences. Conclusions: Implementation of a knowledge-based CDSS with standardized order sets significantly reduced PFT ordering errors and variability, improving guideline adherence and care quality. Continued refinement and integration with evolving technologies are essential for broader applicability.
Clinical Outcomes of Multiligament Knee Fracture Dislocation at Minimum 2-year Follow-up
Tagliero, Adam J. , Williams, Jaques, Iyer, Sanathan , Yanamala, Sandeep , Rechter, Griffin, Page, Brendan, Stuart, Michael J. , Krych, Aaron, Levy, Bruce, Tagliero, Adam , Stuart, Michael J , Rechter, Griffin R. , Page, Brendan E. , Krych, Aaron J. , Levy, Bruce

Mayo Clinic

The Journal of Knee Surgery | July 30, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2908-2434 | PMID 42532117 Get It

Abstract To report clinical and functional outcomes, including patient-reported outcome measures (PROMs), complications, reoperation rates, and arthritic progression in patients who sustained a knee dislocation (KD) type V fracture dislocation at minimum 2-year follow-up. A retrospective review from a prospectively collected database was performed to identify all patients with a KD type V fracture dislocation between 2001 and 2022 at a single institution. Patient demographics, pre- and postoperative clinical examination findings, intraoperative details, and postoperative complication rates were obtained from medical records. PROMs, including Visual Analog Scale (VAS), Tegner Activity Scale, Lysholm score, and International Knee Documentation Committee Subjective (IKDC) score were analyzed. A total of 11 patients (mean age: 33.9 ± 7.6, mean BMI: 33.5 ± 6.4 kg/m2) were included with a mean follow-up of 6.4 ± 5.4 years. Seven patients (64%) had a tibial plateau fracture involving the weight-bearing surface. Four patients (36%) had a concomitant nerve injury, one patient (9%) had a concomitant vascular injury, three patients (27%) had a concomitant cartilage injury (ICRS grade 3 + ), and seven patients (64%) had a concomitant meniscus injury. In all, 10 patients (82%) underwent fracture fixation. The mean postoperative Kellgren-Lawrence (KL) grade was 3.0 ± 1.0. Postoperative PROMs included VAS at rest of 2.0 ± 2.3, VAS with activity of 3.3 ± 3.2, IKDC of 68.3 ± 22.1, Lysholm of 79.0 ± 23.6, and Tegner of 4.3 ± 1.7. Nine patients (83%) experienced a complication, with four (36%) patients requiring a subsequent reoperation. Patients with a KD V fracture dislocation who underwent surgical management demonstrated high complication and reoperation rates with advanced radiographic evidence of osteoarthritis but ultimately satisfactory functional outcomes at mid-term follow-up. These findings underscore the complexity of KD V injuries and the importance of early recognition, multidisciplinary surgical planning, and patient counseling regarding the prolonged recovery and likelihood of residual symptoms. Level of evidence is IV—retrospective case series.
INtraVESical immunoTherapy ( INVEST ) prior to radical cystectomy for bladder cancer: trial protocol
Whelan, Ruby Smith , Senior, Ethan, Kendall, Jessica , Oughton, Jamie B. , Collinson, Fiona, Griffin, Jon , Hubbard, Rachel, Kennish, Steven, Noon, Aidan, Riaz, Irbaz B., Telliez, Julie, Catto, James W. F., Hussain, Syed A., Lister-Whelan, Ruby , Senior, Ethan R, Collinson, Dr Fiona, Kennish, Steven, Noon, Aidan P. , Rosario, Derek J. , Riaz, Irbaz B, Telliez, J., Catto, James W.F. , Hussain, Syed A.

Mayo Clinic

BJU International | July 28, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/bju.70387 | PMID 42515859 Get It

Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease. Treatments overcoming these limitations are needed to improve HRNMIBC outcomes. Many novel agents have been approved in recent years (including systemic pembrolizumab, nogapendekin alfa inbakicept‐pmln, N‐803), but long‐term efficacy is unknown. Given advanced bladder cancer findings, we believe direct intravesical administration of atezolizumab may aid with managing HRNMIBC or muscle‐invasive bladder cancer in patients who are ineligible for cisplatin‐based neoadjuvant chemotherapy. Study design The INtraVESical immunoTherapy (INVEST) trial is a UK‐based, open‐label, non‐randomised, single‐centre, Phase Ib dose escalation, window of opportunity study exploring atezolizumab administration via intravesical routes (passive instillation and direct injection [sub‐urothelial]) in patients with bladder cancer with all stages undergoing RC. For both routes, an initial dose confirmation stage will determine toxicity and recommended atezolizumab dosage, followed by a dose expansion stage to further evaluate safety and toxicity at the recommended dose. Endpoints We aim to investigate safety (primary) and preliminary activity (secondary) of intravesical atezolizumab delivered by passive instillation and direct injection into the tumour/bladder wall in patients with bladder urothelial cell carcinoma prior to RC. Primary endpoints include dose limiting toxicities and adverse events. Secondary endpoints include progression‐free survival, pathological complete response rate and treatment compliance. Exploratory endpoints include pharmacokinetic profile (assessed by serum and urine concentrations at prespecified timepoints), spatial analysis of atezolizumab distribution within RC tissue by imaging mass spectrometry and overall survival. Patients and Methods Atezolizumab will be administered intravesically by either passive instillation or direct injection into the tumour/bladder wall. Cohorts will receive either 600 mg or 1200 mg doses administered as a single dose or as multiple doses (weekly for 3–6 weeks). Trial Registration International Standard Randomised Controlled Trial Number: ISRCTN15842444 , registered 2 December 2022.
Fever of Unknown Origin Solved With Novel Diagnostic Tool
Pomerantz, Lauren , Saleh, Omar M. Abu, Griffin, Nick, Pomerantz, Lauren D , Saleh, Omar Abu , Griffin, Natalie E.

Mayo Clinic

Annals of Internal Medicine: Clinical Cases | July 21, 2026 | Volume: 5 | Issue: 7 | Pages: No page available

10.7326/aimcc.2026.0253 Get It

Arthroscopic Posterior Capsular Releases for Recalcitrant Arthrofibrosis
Daniel, Adam V. , Rechter, Griffin R., Barrera, Lindsay E., Hevesi, Mario , Okoroha, Kelechi R. , Krych, Aaron J., Levy, Bruce A. , Levy, Bruce A , Hevesi, Mario , Rechter, Griffin R. , Barrera, Lindsay , Tagliero, Adam J. , Krych, Aaron J. , Levy, Bruce A.

Mayo Clinic

Video Journal of Sports Medicine | July 6, 2026 | Volume: 6 | Issue: 4 | Pages: No page available

10.1177/26350254261416547 | PMID 42415920 Get It

Background: The origin of arthrofibrosis of the knee is multifactorial; however, it is more commonly seen in patients with arthritis, prolonged immobility, or a history of trauma or surgery to the knee. Arthrofibrosis that results in a flexion contracture of the knee is commonly attributable to scarring and shortening of the posterior joint capsule as seen in the setting of operative intervention, such as anterior cruciate ligament reconstruction (ACLR). Indications: Arthroscopic posterior capsular releases of the knee are indicated in patients with recalcitrant arthrofibrosis who have (1) failed nonoperative management and (2) a flexion contracture of ≥10°. Technique Description: This arthroscopic technique utilizes posteromedial and posterolateral portals in addition to the standard anteromedial and anterolateral portals. A transpatellar tendon portal may also be used to create the posterolateral portal. Both a 30° and a 70° arthroscope are used to better visualize the posteromedial and posterolateral inferior and superior releases. In addition to releases of the capsule both inferiorly and posteriorly, the medial and lateral gastrocnemius tendons can be partially released from the femur to allow for a more adequate release. The 70° arthroscope is necessary to access the capsule posterior to the posterior cruciate ligament to ensure complete release. Results: This procedure is typically reserved for patients who have failed conservative management with extension splinting, physical therapy, and the use of corticosteroids. Persistent arthrofibrosis with flexion contracture can occur after ACLR, with an incidence as high as 38% in some series. The specific technique described in this video has documented patient-reported outcomes of achieving full extension in >90% of patients after an arthroscopic posterior capsular release at final follow-up. Discussion/Conclusion: Recalcitrant arthrofibrosis leading to a persisting extension deficit can be devastating for a patient, as it results in increased pain and stiffness, as well as a significant decrease in functionality. Performing a posterior capsular release in addition to the standard manipulation under anesthesia and lysis of adhesions/synovectomy will allow for greater knee range of motion, particularly greater knee extension. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.
Caregiver Reports of Lucid Episodes in Alzheimer’s Dementia and Lewy Body Dementias
Bangerter, Lauren R. , Kim, Kyungmin , Liu, Yin, Radford, Jonathan Graff, Liu, Yin, Lapid, Maria I. , Griffin, Joan M. , Kim, Kyungmin

Mayo Clinic

Journal of Geriatric Psychiatry and Neurology | July 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/08919887261464594 | PMID 42387273 Get It

Purpose of Research Lucidity is the transient recovery of abilities and communication that were seemingly lost among people living with dementia (PLWD). This study describes lucid episodes reported by Alzheimer’s dementia (AD) and Lewy Body Dementias (LBD) caregivers. We analyzed survey data from 212 current AD ( n = 191) and LBD caregivers who reported the frequency, duration, and characteristics of 653 lucid episodes witnessed in the past month. Major Findings Most AD caregivers (67%) and LBD caregivers (81%) witnessed a lucid episode within the past month. LBD caregivers reported lucid episodes with greater changes in awareness and communication, compared to AD caregivers. LBD caregivers reported longer lucid episodes and that the PLWD knew about their change in lucidity, compared to AD caregivers. Conclusions Findings suggest that differences in lucid episode intensity, timing, and meta-awareness between AD and LBD are possible and may inform care strategies for PLWD.
Association of Sleep Duration Ratio with a Reduced Risk of Heart Failure: Analysis of the 2017–2023 National Health and Nutrition Examination Survey
Kulthamrongsri, Narathorn , Suenghataiphorn, Thanathip , Sripusanapan, Adivitch , Siramongkholkarn, Smuch , Srikulmontri, Thitiphan , Puchongmart, Chanokporn , Thiravetyan, Ben , Ngarmukos, Kridhitach, Lorlowhakarn, Koravich , Tangprasittichok, Nathasith , Nuqali, Abdulelah, Tantisattamo, Ekamol , Suenghataiphorn, Thanathip , Yinadsawaphan, Thanaboon , Thiravetyan, Ben , Ngarmukos, Kridhitach , Tangprasittichok, Nathasith , Tantisattamo, Ekamol , Kulthamrongsri, Narathorn

Mayo Clinic

Journal of Clinical Medicine | June 30, 2026 | Volume: 15 | Issue: 13 | Pages: 5047

10.3390/jcm15135047 | PMID 42452509 Get It

Background/Objectives: In the United States, HF prevalence is projected to progressively rise by 2030. Prior research suggests a strong association between reduced sleep duration and increased cardiovascular disease and HF risk. This study introduces an alternative parameter, the weekend sleep recovery (WSR), measured by the weekend-to-weekday sleep duration ratio (SDR), to evaluate its association with HF risk. Methods: We conducted a cross-sectional analysis of NHANES (National Health and Nutrition Examination Survey) 2017–2023 to examine self-reported sleep patterns. Participants were classified as WSR (SDR > 1) or non-WSR (SDR ≤ 1). Multivariate logistic regression assessed the association between WSR and HF, adjusting for demographics and comorbidities. Results: Among 8320 participants included in the fully adjusted analysis, WSR was associated with lower odds of HF compared with non-WSR (adjusted OR 0.73, 95% CI 0.55–0.96; p = 0.026). A significant interaction was observed between WSR and weekday sleep duration (P for interaction = 0.003), whereas no interaction was found with weekend sleep duration. In exploratory subgroup analyses, nominally significant associations were observed in several clinical subgroups; however, after correction for multiple comparisons, only participants without dyslipidemia retained statistical significance. No significant effect modification by race/ethnicity was observed (P for interaction = 0.436). Conclusions: Weekend sleep recovery was associated with lower odds of HF in this cross-sectional study. The association varied according to weekday sleep duration but was generally consistent across racial/ethnic groups. Given the observational design, these findings should be interpreted as associative rather than causal and warrant confirmation in prospective studies.
How to Set Anterior and Posterior Tibial Translation for Combined Anterior Cruciate Ligament and Posterior Cruciate Ligament Reconstruction
Rechter, Griffin R. , Khan, Abid M. , Tagliero, Adam J. , Kannan, Abhishek , Levy, Brooke R., Krych, Aaron J. , Levy, Bruce A. , Kannan, Abhishek S , Krych, Aaron J , Tagliero, Adam

Mayo Clinic

Arthroscopy Techniques | June 13, 2026 | Volume: 15 | Issue: 8 | Pages: No page available

10.1002/atn2.70113 | PMID 42499864 Get It

Abstract Anterior and posterior cruciate ligament (ACL and PCL) reconstruction poses the risk of residual anterior or posterior tibial translation, respectively. As a result, patients may have residual knee instability and laxity, which can contribute to poor outcomes and graft failure. Ultimately, minimizing anterior and posterior tibial translation through proper ACL and PCL graft tensioning has the potential to improve clinical and functional outcomes in the setting of ACL and PCL reconstruction surgery. This technique aims to show a reproducible method for “setting” anterior and posterior tibial translation in the setting of ACL and PCL reconstructions.